Literature DB >> 21750895

The new Belgian law on biobanks: some comments from an ethical perspective.

Sigrid Sterckx1, Kristof Van Assche.   

Abstract

On 19 December 2008 the Official Journal of Belgium published the 'Law regarding the procurement and use of human body material destined for human medical applications or for scientific research purposes'. This paper will comment on various aspects of the Law: its scope of application (what is understood by 'body material'?); its concept of 'residual human body material' (with far-reaching implications for the type of consent required for research); the nature of actions with and uses of human body material that are explicitly prohibited; the right of donors to be informed of relevant information revealed by the use of their body material; and the special responsibilities placed on hospital ethics committees. As will be argued in this paper, several of these provisions are highly problematic from an ethical point of view, especially those relating to consent. Meanwhile, the Minister of Public Health has asked the Belgian Advisory Committee on Bioethics for advice on the incorporation of the 'presumed consent' model, that applies to post mortem organ donation, into the biobank Law's provisions on post mortem removal and use of body material. This aspect of the Law effectively extends the 'presumed consent' regime, both from organs to body material in general, and from therapeutic uses to research uses.

Entities:  

Mesh:

Year:  2011        PMID: 21750895     DOI: 10.1007/s10728-011-0181-0

Source DB:  PubMed          Journal:  Health Care Anal        ISSN: 1065-3058


  4 in total

Review 1.  No consent should be needed for using leftover body material for scientific purposes. Against.

Authors:  Julian Savulescu
Journal:  BMJ       Date:  2002-09-21

2.  Broadening consent--and diluting ethics?

Authors:  B Hofmann
Journal:  J Med Ethics       Date:  2009-02       Impact factor: 2.903

3.  Convention for the protection of human rights and dignity of the human being with regard to the application of biology and medicine: convention on human rights and biomedicine (adopted by the Committee of Ministers on 19 November 1996). Council of Europe Convention of Biomedicine.

Authors: 
Journal:  Hum Reprod       Date:  1997-09       Impact factor: 6.918

4.  For the safety and benefit of current and future patients.

Authors:  Mats G Hansson
Journal:  Pathobiology       Date:  2007       Impact factor: 4.342

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.